BioSpace News Archive

Perspectum announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Hepatica, a precision oncology decision support tool for liver cancer.

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Waters Corporation announced that it received a score of 95 out of 100 on the 2021 Corporate Equality Index, the Human Rights Campaign Foundation’s annual scorecard for LGBTQ workplace equality.

For the seventh consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation’s (HRC) annual Corporate Equality Index (the Index).

Dynatronics Corporation, a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced the introduction of a new bariatric stand-in table with motorized patient lift and a premium laminated H-brace treatment table.

The Versiti Blood Research Institute has been awarded a $12.3 million research grant by the National Institutes of Health’s National Heart, Lung and Blood Institute to support Versiti’s research of how blood production is governed by sugars and how sugars change amid cancer and disease.

Binovi Technologies Corp., a leader in neuro-vision performance technology, is proud to announce a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs.

Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company appointed Ms. Belen Toledo MSc.,

Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned subsidiary of Bayer AG, today announced that the clinical team from Brain Neurotherapy Bio, Inc., a gene therapy company based in Columbus, Ohio, has joined AskBio to expand its clinical pipeline for the treatment of neurodegenerative disorders.

Virios Therapeutics, Inc. (Nasdaq: VIRI), a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, announced today that Greg Duncan, Chairman and Chief Executive Officer, will present a company overview at the virtual 2021 BIO CEO & Investor Conference to be held from February 16-18, 2021.